Sign in to continue:

Monday, February 23rd, 2026

Kingboard Holdings Announces Over 165% Surge in Net Profit for 2025 Driven by Robust Laminates and Investment Business Demand

Kingboard Holdings Limited Issues Positive Profit Alert for FY2025

Kingboard Holdings Limited Announces Significant Profit Surge for 2025

Key Highlights

  • Substantial Increase in Net Profit: Kingboard Holdings Limited (“KBH”) expects to record a net profit exceeding HK\$4.32 billion for the year ended 31 December 2025, representing an increase of more than 165% compared with the corresponding period in 2024.
  • Primary Growth Drivers:
    • Investment Business Segment: The investment business reporting segment has contributed significantly to the surge in profitability.
    • Laminates Business Segment: The laminates segment, including its upstream materials such as fibreglass yarn, fibreglass fabric, and copper foil, has seen both unit prices and sales quantities rise sharply, driven by robust market demand.
  • Market Demand Remains Strong: The company reports continued robust demand for laminates and upstream materials, which has positively impacted pricing and sales volumes.

Details for Shareholders and Potential Investors

  • Price-Sensitive Information: The expected increase in net profit, representing more than a doubling of the prior year’s profit, is a significant development and is likely to be price sensitive. Such a strong financial performance could have a meaningful impact on KBH’s share price.
  • Preliminary Nature of Results: The figures provided are based on unaudited management accounts and are subject to finalization and adjustments. The results have not yet been audited or reviewed by the KBH audit committee.
  • Upcoming Announcements: The final audited results for the year ended 31 December 2025 will be disclosed in the company’s annual results announcement, which is expected to be published before the end of March 2026, in accordance with the requirements of the Hong Kong Listing Rules.
  • Advisory for Investors: Shareholders and potential investors are strongly advised to exercise caution in their dealings with KBH’s securities until the full audited annual results are released.

Board and Management

  • The announcement was authorized by the KBH Board, which comprises a mix of executive and independent non-executive directors, ensuring proper governance and oversight over company disclosures.
  • Company Secretary: Lo Ka Leong
  • Announcement Date: 23 February 2026

What This Means for Shareholders

The forecasted profit surge is a highly positive result for KBH, indicating strong business momentum, especially in the laminates and investment segments. The sharp increase in both pricing and sales volume of laminates and upstream materials underscores KBH’s strong market positioning and operational performance. This development is very likely to be price sensitive and could drive material movement in KBH’s share price upon market reaction.

However, as the information is based on preliminary management accounts and has not yet been audited, investors should remain alert to possible revisions when the final audited results are published.

Disclaimer

This article is for informational purposes only and does not constitute financial advice. Investors are reminded that the information provided is based on unaudited preliminary data and is subject to finalization. Please refer to the official audited results announcement for the year ended 31 December 2025, expected before the end of March 2026, for the most accurate and complete financial information. Exercise caution when making investment decisions relating to Kingboard Holdings Limited.


View KINGBOARD HLDG Historical chart here



BUTONG GROUP Announces Trustee Purchase of Shares for Share Award Scheme on February 16, 2026

BUTONG GROUP Share Award Scheme Update: Trustee Purchases Shares BUTONG GROUP Announces Trustee’s Purchase of Shares for Share Award Scheme Date: February 16, 2026 Company: BUTONG GROUP (Stock Code: 6090) Key Highlights Share Purchase...

CStone’s Sugemalimab Receives UK MHRA Approval for Stage III NSCLC, Expanding Global Oncology Footprint

CStone Pharmaceuticals: Sugemalimab Receives UK MHRA Approval for Stage III NSCLC CStone Pharmaceuticals: Sugemalimab Receives UK MHRA Approval for Stage III NSCLC Key Highlights Sugemalimab, CStone’s innovative anti-PD-L1 monoclonal antibody, has received a new...

Disclosure of Share Dealings in ENN Energy Holdings Limited by Morgan Stanley & Co. International plc – February 2026

Key Disclosure: Morgan Stanley Dealings in ENN Energy Holdings Limited Shares Morgan Stanley Discloses Significant Dealings in ENN Energy Holdings Shares Amid Privatisation Scheme Date: 23 February 2026 Subject: Disclosure of Dealings in ENN...

   Ad